Latest papers

[The role of matrixmetalloproteinases in the tumor growth and metastasis].

Cellular and molecular mechanisms of cancer cell invasion.

Matrix metalloproteinases involvement in pathologic conditions.

Matrix metalloproteinases in vascular disease--a potential therapeutic target?

Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy.

MMPs/TIMPs and inflammatory signalling de-regulation in human incisional hernia tissues.

The association of MMP-9 enzyme activity, MMP-9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer.

Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis.

Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review).

Vascular regression and survival are differentially regulated by MT1-MMP and TIMPs in the aortic ring model of angiogenesis

Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-Induced Lung Injury

Thoracic Aortic Dissection: Are Matrix Metalloproteinases Involved?

Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes.

Protective effects of doxycycline in ischemia/reperfusion injury on kidney.

Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention.

Paracrine and juxtacrine lymphocyte enhancement of adherent macrophage and foreign body giant cell activation.

Experimental heart transplantation: effect of cyclosporine on expression and activity of metzincins.

[Triptolide evaluates DNA methylation level of matrix metalloproteinase 9 gene in human fibrosarcoma HT-1080 cells].

Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer.

[Change of cartilage matrix metabolism under stress].